Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Austrian Adult Cardiac Surgery Registry: Structure and Governance of a National Quality Assurance System.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Prognostic Impact of Qualitative and Quantitative Mitral Valve Calcification in Transapical Transcatheter Mitral Valve Replacement: A Sub-Analysis of the TENDER Registry.

Journal of clinical medicine·2026
Same author

CT-Based Annular Dimensions in Transcatheter Mitral Valve Replacement: A Multicenter Registry Study.

The Annals of thoracic surgery·2026
Same author

Evolution of Right Ventricular Function and Pulmonary Artery Coupling After Transapical Transcatheter Mitral Valve Replacement.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Three-Year Outcomes After Surgical Aortic Valve Replacement With a Bioprosthetic Valve from the Multi-Centre IMPACT Registry.

Interdisciplinary cardiovascular and thoracic surgery·2026

Related Experiment Video

Updated: May 23, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Sutureless Aortic Valve Replacement via Partial Sternotomy.

Sven Martens1, Andreas Zierer, Anja Ploss

  • 1From the Department of Thoracic and Cardiovascular Surgery, JWGoethe University Hospital, Frankfurt am Main, Germany.

Innovations (Philadelphia, Pa.)
|March 23, 2012
PubMed
Summary
This summary is machine-generated.

Sutureless aortic valve replacement using the ATS 3f Enable bioprosthesis is feasible and safe in elderly patients. This minimally invasive approach shows promising hemodynamic results and may be an alternative for high-comorbidity patients.

More Related Videos

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Related Experiment Videos

Last Updated: May 23, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science
  • Geriatric Medicine

Background:

  • Aortic valve stenosis (AS) is a common valvular heart disease in the elderly.
  • Tissue valves are preferred for aortic valve replacement (AVR) in elderly patients.
  • Stentless bioprostheses offer improved hemodynamics but pose implantation challenges, especially in minimally invasive AVR.

Purpose of the Study:

  • To evaluate the feasibility, safety, and early outcomes of sutureless aortic valve replacement using the ATS 3f Enable bioprosthesis.
  • To assess the hemodynamic performance of the sutureless bioprosthesis in elderly patients undergoing AVR via partial upper sternotomy.
  • To determine the potential of this technique as an alternative for high-comorbidity patients.

Main Methods:

  • A prospective study of 22 elderly patients (mean age 79 years) with symptomatic AS.
  • Aortic valve replacement performed via partial upper sternotomy using the sutureless ATS 3f Enable bioprosthesis.
  • Procedures utilized cardiopulmonary bypass (CPB) with cardioplegic arrest; subvalvular myectomy was performed in two patients.

Main Results:

  • Sutureless valve implantation time averaged 10 ± 6 minutes.
  • Mean CPB and aortic crossclamp times were 87 ± 16 and 55 ± 11 minutes, respectively.
  • Early mortality was 9% (2 patients); no paravalvular leakage was observed. Mean transvalvular gradients were low at discharge (9 ± 6 mm Hg) and 1-year follow-up (8 ± 2 mm Hg).

Conclusions:

  • Sutureless AVR with the ATS 3f Enable bioprosthesis via partial sternotomy is feasible and safe.
  • This minimally invasive approach demonstrates promising hemodynamic results with low gradients.
  • Sutureless valve implantation may offer an alternative treatment option for elderly patients with high comorbidity and AS.